Cancer - November 2015 Archives

...

It was 33 years ago that President Ronald Reagan launched the first national Alzheimer's disease awareness campaign. Since then, research has developed ways to manage symptoms ... but ...

It was 33 years ago that President Ronald Reagan launched the first national Alzheimer's disease awareness campaign. Since then, research has developed ways to manage ...

Do you know what health conditions run in your family? Take advantage of upcoming holiday gatherings to find out. Having access to this vital ...

It was 33 years ago that President Ronald Reagan launched the first national Alzheimer's disease awareness campaign. Since then, research has developed ways to manage symptoms ... but ...

November is Pancreatic Cancer Awareness Month, and Mayo Clinic Cancer Center experts are available to discuss this often fatal illness, risk factors, treatments and advances ...

On Mayo Clinic Radio, cancer surgeon Dr. Mark Truty discusses the latest in treatment for pancreatic cancer, and pancreatic cancer survivor Dick Hansen shares his ...

According to the National Cancer Institute, by the end of this year 49,000 people will be diagnosed with pancreatic cancer ... and an estimated 41,000 ...

According to the National Cancer Institute, by the end of this year 49,000 people will be diagnosed with pancreatic cancer ... and an estimated 41,000 ...

Watch Today's  Mayo Clinic Minute For decades, women have taken oral contraceptives as a method of birth control and to treat a number of other ...

November is Pancreatic Cancer Awareness Month. Do you have questions about pancreatic cancer diagnosis and treatment, including chemotherapy, radiation and surgery? Share them with ...

ROCHESTER, Minn. — Patients who develop ovarian cancer appear to have better outcomes if they have a history of oral contraceptive use, according to a study by Mayo Clinic researchers published in the current issue of the journal BMC Cancer. “Multiple studies from a variety of sources have indicated that oral contraceptives are associated with a reduced risk of ovarian cancer, one of the most deadly cancers in women,” says Aminah Jatoi, M.D., an oncologist at Mayo Clinic and co-lead author of the study. “However, few studies have explored the connection between the pill and outcomes in patients who ultimately develop the disease.” In their study, Dr. Jatoi and co-author Ellen L. Goode, Ph.D., an epidemiologist at Mayo Clinic, examined the outcomes of ovarian cancer patients who were seen at Mayo Clinic from 2000 through 2013. Each patient was given a risk factor questionnaire about prior oral contraceptive use. Of the 1,398 patients who completed the questionnaire, 827 responded that they had previously taken birth control pills. MEDIA CONTACT: Joe Dangor, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu  Journalists: Sound bites with Dr. Jatoi are available in the downloads. https://www.youtube.com/watch?v=cZubD3SK0L8